AaronNagielMD

Ophthalmology • Los Angeles, CA

Physician

Join to view full profile

Dr. Nagiel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nagiel's full profile

Already have an account?

Office
4650 W Sunset Blvd
# 88
Los Angeles, CA 90027
Phone+1 323-660-2450

Fax+1 323-361-7993

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 2012 - 2015
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 2011 - 2014
Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2011 - 2012
Weill Cornell MedicineClass of 2011

Certifications & Licensure

CA State Medical License 2013 - 2025
American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

35 citations
Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development
Thomas A. Ciulla, Rehan M. Hussain, Audina M. Berrocal, Aaron Nagiel
Expert Opinion on Biological Therapy. 2020-03-25
37 citations
Evaluation of a Deep Learning-Derived Quantitative Retinopathy of Prematurity Severity Scale.
J. Peter Campbell, Sang Jin Kim, James M. Brown, Susan Ostmo, R.V. Paul Chan
Ophthalmology. 2021-07-01
132 citations
Retinal stem cell transplantation: Balancing safety and potential.
Mandeep S. Singh, Susanna Soon Chun Park, Thomas A. Albini, M. Valeria Canto-Soler, Henry Klassen
Progress in Retinal and Eye Research. 2020-03-01

Press Mentions

Let’s Talk About Gene Therapy for Inherited Retinal DiseasesAugust 11th, 2021
The Differential Diagnosis of Central Serous Chorioretinopathy and Other Diseases Associated with Subretinal Fluid in the MaculaMarch 11th, 2021
SUBSPECIALTY NEWS: Results for Combination Therapy for DME, FDA Asks for Information on Xipere, Depo-Medrol Retinal Toxicity, and MoreOctober 1st, 2019
Join now to see all

Grant Support

Specificity Of Neuronal Connections In The Zebrafish Lateral LINENational Institute Of Neurological Disorders And Stroke2008–2011